Valuation
- Market cap
- 15,446,000
- Revenue TTM
- $41,710,000
- Net income TTM
- $-10,540,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- -25.27%
- Debt to equity
- 0.78
Trading
- Volume
- 334,700
- Avg volume
- 623,730
- Day's range
- $1.00 – $1.12
- Shares out
- 14,852,000
- Stochastic %K
- 7%
- Beta
- 0.86
- Analysts
- Sell
- Price target
- $6.00
Company profile
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massac...
Show more
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- Phone
- 781 245 1325
- Website
- https://www.biofrontera-us.com
- Address
- 660 Main Street, 1st Floor, Woburn, United States
Latest news
No headlines yet.
